Methylated CpG-Containing Plasmid Activates the Immune System

Scandinavian Journal of Immunology

Volumn 59, Issue 2, 2004, Pages 143-151

  Cornelie S ^a   Poulain Godefroy, O ^a   Lund, C ^a   Vendeville, C ^a   Ban, E ^a   Capron, M ^a   Riveau, G ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DNA; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; PLASMID VECTOR; RECOMBINANT ANTIGEN; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BLOOD; CELL MIGRATION; CHEMISTRY; CONTROLLED STUDY; CPG ISLAND; CYTOCHEMISTRY; DNA METHYLATION; DOSE RESPONSE; FEMALE; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOSTIMULATION; LANGERHANS CELL; METHYLATION; MOUSE; MOUSE STRAIN; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MOTIF; RNA SYNTHESIS;

ANIMALS; ANTIBODY FORMATION; CPG ISLANDS; DNA; DNA METHYLATION; DNA, BACTERIAL; FEMALE; HISTOCYTOCHEMISTRY; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; PLASMIDS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; VACCINES, DNA;

EID: 1342331428     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01373.x     Document Type: Article

References (50)

1. Yamamoto S, Yamamoto T, Shimada S et al. DNA from bacteria, but not vertebrates, induces interferons, activated NK cells and inhibits tumors growth. Microbiol Immunol 1992;36:383.
2. Tokunaga T. Antitumor activity of deoxyribonucleic acid fraction of Mycobacterium bovis BCG I. J Natl Cancer Inst 1984;72:955-62.
3. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligodeoxynucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 1992;148:4072-6.
4. Krieg AM, Yi A-K, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995;374:546-9.
5. Cardon LR, Buge C, Clayton DA, Karlin S. Pervasive CpG suppression in animal mitochondrial genomes. Proc Natl Acad Sci USA 1994;91:3799.
6. Lipford GB, Bauer M, Blank C, Reiter R, Wagner H, Heeg K. CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants. Eur J Immunol 1997;27:2340-4.
7. Sparwasser T, Miethke T, Lipford G, Erdmann A, Heeg K, Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur J Immunol 1997;27:1671-9.
8. Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996;157:2116-22.
9. Lipford GB, Sparwasser T, Bauer M et al. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur J Immunol 1997;27:3420.
10. Segal BM, Klinman DM, Shevach EM. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J Immunol 1997;161:5087.
11. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998;161:3042.
12. Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 1999;96:9305-10.
13. Ban E, Dupré L, Hermann E et al. CpG motifs induce Langerhans cell migration in vivo. Int Immunol 2000;12:737-45.
14. Wang B, Fujisawa H, Zhuang L et al. Depressed Langerhans cells migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 1997;159:6148.
15. Weiner GJ, Liu H-M, Woolgridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA 1997;94:10833-7.
16. Bauer M, Heeg K, Wagner H, Lipford GB. DNA activates human immune cells through a CpG sequence-dependent manner. Immunology 1999;97:699-705.
17. Sun S, Kishimoto H, Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 1998;187:1145-50.
18. Razin A, Friedman J. DNA methylation and its possible biological roles. Prog Nucleic Acid Res Mol Biol 1981;25:33.
19. Hemmi H, Takeushi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-5.
20. Chuang T-H, Lee J, Kline L, Mathison JC, Ulvetich RJ. Toll-like receptor 9 mediates CpG-DNA signaling. J Leukoc Biol 2002;71:538-44.
21. Pisetsky DS. The immunologic properties of DNA. J Immunol 1996;156:421-3.
22. Cornélie S, Wiel E, Lund N et al. Cytosine-phosphate-guanosine (CpG) motifs are sensitizing agents for lipopolysaccharide in toxic shock model. Intensive Care Med 2002;28:1340-7.
23. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356:152-4.
24. Robinson HL. DNA vaccines: basic mechanism and immune responses. Int J Mol Med 1999;4:549-55.
25. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-4.
26. Klinman DM, Yamshchikov G, Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997;158:3635-9.
27. Klinmann DM, Barnhart KM, Conover J. CpG motifs as immune adjuvants. Vaccine 1999;17:19-25.
28. Feltaque DM, Robinson HL. Effect of CpG methylation on isotype and magnitude of antibody responses to influenza hemagglutinin-expressing plasmid. DNA Cell Biol 1999;18:663-70.
29. Poulain-Godefroy O, Mielcarek N, Ivanoff N et al. Bordetella pertussis filamentous hemagglutinin enhances the immunogenicity of liposome-delivered antigen administered intranasally. Infect Immun 1998;66:1764-7.
30. Shelley WB, Juhlin L. Selective uptake of contact allergens by the Langerhans Cell. Arch Dermatol 1977;113:187-92.
31. Renbaum P, Abrahamove D, Fainsod A, Wilson GG, Rottem S, Razin A. Cloning, characterization, and expression in Escherichia coli of the gene coding for the CpG DNA methylase from Spiroplasma sp. strain MQ1 (M SssI). Nucleic Acids Res 1990;18:1145-52.
32. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-60.
33. Roman M, Martin-Orozco E, Goodman JS et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849-54.
34. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M. DNA methylation is a reversible biological signal. Proc Nad Acad Sci USA 1999;96:6107-12.
35. Dupre L, Poulain-Godefroy O, Ban E et al. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol 1997;19:505-13.
36. Raz E, Carson DA, Parker SE et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994;91:9519-23.
37. Babiuk S, Baca-Estrada M, Babiuk LA, Ewen C, Foldvari M. Cutaneous vaccination. the skin as an immunologically active tissue and the challenge of antigen delivery. J Control Release 2000;66:199-214.
38. Bauer S, Kirschning CJ, Häcker H et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001;98:9237-42.
39. Kadowaki N, Ho S, Antonenko S et al. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863-9.
40. + DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 2003;33:827-33.
41. Goeckeritz BE, Flora M, Witherspoon K et al. Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion. Int Immunol 1999;11:1693-700.
42. Chen Y, Lenert P, Weeratna R et al. identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 2001;8:1024-32.
43. Raz E, Tighe H, Sato Y et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5.
44. + lymphocytes. J Immunol 1995;155:259-65.
45. Ishii KJ, Suzuki K, Coban C et al. Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 2001;167:2602-7.
46. Bandholtz L, Guo Y, Palmberg C et al. Hsp90 binds CpG oligonucleotides directly: implications for hsp90 as a missing link in CpG signaling and recognition. Cell Mol Life Sci 2003;60:422-9.
47. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B cells. J Immunol 2001;167:2921-8.
48. Lee SW, Song MK, Baek KH et al. Effects of a hexameric deoxyriboguanosine run conjugation into CpG oligodeoxynucleotides on their immunostimulatory potentials. J Immunol 2000;165:3631-9.
49. O'Neill LA, Fitzgerald KA, Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003;24:286-90.
50. Verthelyi D, Zeuner RA. Differential signaling by CpG DNA in DCs and B cells: not just TLR9. Trends Immunol 2003;24:519-22.